About C-CAMP
C-CAMP, an accelerator and incubator program founded in 2010, is based in Bengaluru, India. With a presence in 10 countries, it has supported around 639 startups in sectors like Life Sciences, HealthTech. As of Nov 2026, C-CAMP has witnessed 6 portfolio exits. Most notable companies in
its portfolio include Qure.ai, Trivitron and Strand Life Sciences. The program is backed by a team of 61 people who primarily support Seed startups based in India. Its latest investment was a $150K Seed round in Vyuhaa Med Data on Jan 10, 2026 along with MeitY Startup Hub.
Key Metrics
Founded Year
2010
Location
Bengaluru, India
Sectors of Investment
Stages of Investment
Seed & Grant (prize money)
Locations of Investment
C-CAMP's List of Top Investments
C-CAMP has a portfolio of 639 companies. Their most notable investments are in RCupe Lifesciences and UltraNutri.Their portfolio spans across India, United States, Singapore and 7 more locations. They have invested in Life Sciences, HealthTech, Food and Agriculture Tech and 26 other sectors, across stages such as Seed, Grant (prize money) stages. Here is the list of top investments by C-CAMP:1. Qure.ai
Developer of artificial intelligence software for medical imaging diagnostic analysis. This technology integrates with existing radiology hardware to identify abnormalities in chest scans. The software assists clinicians in detecting lung nodules, tuberculosis, and signs of stroke. It provides automated reporting and workflow coordination tools to support diagnostic decision-making processes. The platform facilitates the management of patient care pathways by flagging findings for review.
Key facts about Qure.ai
- Founded Year: 2016
- Location: Mumbai (India)
- Annual Revenue: ₹100 - ₹500 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $123M
- Employee Count: 287 as on May 31, 2026
- Investors: 360 One, Lightspeed and 49 Others
- Latest Funding Round: Grant (prize money), Jan 22, 2026, $*****
- Highlight: Editors' Pick

2. Trivitron
Provider of medical technology and devices for healthcare industry needs. It offers a range of equipment and solutions utilized in various medical settings. These products support diagnostic, therapeutic, and monitoring processes within the healthcare sector. The company focuses on supplying tools that assist medical professionals.
Key facts about Trivitron
- Founded Year: 1997
- Location: Chennai (India)
- Annual Revenue: ₹100 - ₹500 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $109M
- Employee Count: 593 as on Sep 30, 2026
- Investors: Education Growth Partners, Fidelity Investments and 21 Others
- Latest Funding Round: Series C, Dec 07, 2013, $*****
- Highlight: Editors' Pick
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery. The company provides sequence-based diagnostics and clinical genomic data interpretation services to healthcare establishments. Also, offers solutions for integrated omics analysis, image management, systems biology modeling, and molecular modeling.
Key facts about Strand Life Sciences
- Founded Year: 2000
- Location: Bengaluru (India)
- Annual Revenue: ₹100 - ₹500 Cr as on Mar 31, 2026
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $34.9M
- Employee Count: 525 as on Aug 31, 2025
- Investors: WestBridge Capital, Quadria Capital and 92 Others
- Latest Funding Round: Series C, Feb 07, 2018, $*****
- Highlight: Acquired

4. Tricog
Provider of AI-enabled platform for remote cardiac diagnosis and management. The platform offers solutions for clinics, hospitals, diagnostics centers, and public health organizations. It facilitates timely and accurate electrocardiogram interpretation, workflow digitization, and integration with existing laboratory information systems. The platform aims to improve access to cardiac care and reduce mortality rates.
Key facts about Tricog
- Founded Year: 2014
- Location: Bengaluru (India)
- Annual Revenue: ₹50 - ₹100 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $30M
- Employee Count: 371 as on Sep 30, 2026
- Investors: Inventus Capital Partners, Aflac Ventures and 28 Others
- Latest Funding Round: Series B, Apr 20, 2023, $*****
- Highlight: Editors' Pick
5. Forus Health
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms. These devices are designed for acquiring, storing, and transmitting images of the eye's anterior and posterior segments, facilitating the diagnosis of various ocular diseases. The cloud-based platform integrates with the imaging devices, enabling remote diagnosis and efficient monitoring of patients. The company's technology aims to improve access to eye care, particularly in underserved areas. The devices are designed for ease of use and affordability, making them suitable for a wide range of healthcare settings.
Key facts about Forus Health
- Founded Year: 2010
- Location: Bengaluru (India)
- Annual Revenue: ₹50 - ₹100 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $18.1M
- Employee Count: 171 as on Apr 30, 2025
- Investors: Chiratae Ventures, Forward Capital and 15 Others
- Latest Funding Round: Series B, Nov 03, 2025, $*****
- Highlight: Editors' Pick
C-CAMP's Year-on-Year Investment Trends
C-CAMP has invested in 639 companies over the last 9 years, with an average of 5 new investments annually in the last 5 years. In 2025, it made 6 investments, while as of Jan 2026, it has made 1 investment in this year. Its most recent first time investment was in Vyuhaa Med Data and most recent follow-on round was in AIkenist.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 6 | 0 | 6 |
2024 | 5 | 3 | 8 |
2023 | 5 | 1 | 6 |
2022 | 7 | 4 | 11 |
2021 | 11 | 2 | 13 |
2020 | 11 | 3 | 14 |
2019 | 4 | 0 | 4 |
2018 | 5 | 0 | 5 |
2017 | 1 | 0 | 1 |
C-CAMP's Investments by Stage
C-CAMP has made 43 investments in Seed stage with an average round size of $273K and 13 investments in Grant (prize money) stage.Stage of entry | No. of Investments |
|---|---|
Seed | 43 |
Grant (prize money) | 13 |
Note: We have considered here, only first round of investments
C-CAMP's Investments by Sector
C-CAMP has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, Sustainability Tech, Enterprise Applications and High Tech. Notably, it has invested in 439 Enterprise (B2B) companies, 407 Tech companies, 142 Tech hardware companies and at least 131 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 29 |
HealthTech | 17 |
Sustainability Tech | 14 |
Enterprise Applications | 11 |
High Tech | 10 |
Others | 41 |
Note: We have considered here, only first round of investments
C-CAMP's Investments by Geography
C-CAMP has made most investments in India (56), followed by United States where it has made 2 investments.Country | No. of Investments |
|---|---|
India | 56 |
United States | 2 |
Note: We have considered here, only first round of investments
C-CAMP's recent investments
C-CAMP has made 1 investments in 2026 so far - Vyuhaa Med Data.Here are the most recent investments by C-CAMP:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 10, 2026 | India | Seed | 4054 | ||
Dec 09, 2025 | India | Seed | 3178 | ||
Nov 25, 2025 | India | Seed | 5270 | [+2] | |
Aug 30, 2025 | India | Seed | 4125 | - | |
Apr 04, 2025 | India | Seed | 6480 | - |
IPOs and Publicly Listed companies in C-CAMP's Portfolio
2 of C-CAMP's portfolio companies have become public. Q-Line Biotech got listed on the National Stock Exchange (NSE), in May 2026 at marketcap of $83.5M and SD Biosensor got listed on the Korea Exchange (KRX) at marketcap of $4.69B.Here are C-CAMP's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 29, 2026 | - | - | 2171 | |
Jul 16, 2021 | - | - | 8676 |
Acquired companies in C-CAMP's Portfolio
4 companies from C-CAMP's portfolio have been acquired. The most recent acquisition was Predible in May 2022 by nference for $*****.Here are C-CAMP's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 13, 2022 | - | - | 8758 | |
Sep 03, 2021 | - | - | 9734 | |
Aug 26, 2021 | - | - | 7388 | |
Dec 29, 2009 | - | - | 9046 |
Team profile of C-CAMP
C-CAMP has a team of 61 members including 6 Partners and 7 Principals located in India. C-CAMP's team sits on the board of 1 company.Here is a list of top team members in C-CAMP:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Bengaluru | |||
Partner | Bengaluru | - | ||
Partner | - | - | ||
Partner | Bengaluru | - | ||
Partner | Pune | - | ||
Partner | Hyderabad | - | ||
Principal | Bengaluru | - | ||
Principal | Delhi | - | ||
Principal | Bengaluru | - | ||
Principal | Bengaluru | - |
Co-investors of C-CAMP
Over the past 9 years, 698 investors have co-invested in C-CAMP's portfolio companies. This includes funds and angels.
- Invested before C-CAMP: Startup Karnataka, Villgro and 296 others have invested in rounds before C-CAMP. There are 9 companies where Startup Karnataka has invested before C-CAMP and 4 companies where Villgro has invested before C-CAMP.
- Top Co-investors of C-CAMP: 209 investors entered a company along with C-CAMP. These include investors like Social Alpha (5 companies).
- Invested after C-CAMP: A total of 191 investors have invested in C-CAMP's portfolio after their investments. Top Investors include BIRAC (4 companies) and Gates (2 companies).
Recent News related to C-CAMP
•
Agilent Technologies Expands Collaboration with C-CAMP to Enhance Life Sciences Analytics in IndiaIndiaMedToday•May 12, 2026•Agilent, C-CAMP
•
C-CAMP launches 9th edition of national bio entrepreneurship competition with Rs 20 cr at stakeYourStory•May 04, 2026•C-CAMP
•
C-CAMP Partners with Imperial for New Indo-UK Biotech Innovation HubDigitalhealthnews•Apr 23, 2026•C-CAMP, Imperial
•
Healthium Medtech, C-CAMP launch innovations program for surgical, med techIndiaMedToday•Aug 26, 2025•Healthium Medtech, C-CAMP
•
PI Industries expands sustainable agriculture with C-CAMP collaborationBusiness News Today•Feb 22, 2025•PI Industries, C-CAMP
•
Fibroheal Woundcare bags Rs 6.3 Cr in Pre-Series A roundYourStory•Dec 15, 2024•FibroHeal, KITVEN, C-CAMP
•
Water-tech startup Althion raises pre-Series A roundEntrackr•Nov 28, 2024•Althion, Indian Angel Network, BioAngels, C-CAMP and 1 other
•
Prodancy, a C-CAMP supported startup, raises Rs 2.14 Crore to advance innovation in joint replacement surgical consumablesAsian News International•Nov 26, 2024•vizbl.in, Campus Angels Network, Keiretsu Forum, C-CAMP
•
Venture Catalysts leads seed round in AikenistEntrackr•Oct 01, 2024•AIkenist, Venture Catalysts, Quant, C-CAMP and 1 other
•
